Deep learning with convolutional neural network in the assessment of breast cancer molecular subtypes based on US images: a multicenter retrospective study.

Objectives: To evaluate the prediction performance of deep convolutional neural network (DCNN) based on ultrasound (US) images for the assessment of breast cancer molecular subtypes.Methods: A dataset of 4828 US images from 1275 patients with primary breast cancer were used as the training samples....

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 31; no. 6; pp. 3673 - 3683
Autores principales: Jiang, Meng, Zhang, Di, Tang, Shi-Chu, Luo, Xiao-Mao, Chuan, Zhi-Rui, Lv, Wen-Zhi, Jiang, Fan, Ni, Xue-Jun, Cui, Xin-Wu, Dietrich, Christoph F.
Formato: diagnostic images research tables/charts Journal Article
Publicado: Springer Nature Jun2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150343655&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 150343655
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: Jun2021
      vid: 31
      iid: 6
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        150343655
        147212952
        150343655
        NLM33226454
        150343655
        10.1007/s00330-020-07544-8
        NLM33226454
        150343655
      ppf: 3673
      ppct: 10
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Deep learning with convolutional neural network in the assessment of breast cancer molecular subtypes based on US images: a multicenter retrospective study.
      aug:
        au:
          Jiang, Meng
          Zhang, Di
          Tang, Shi-Chu
          Luo, Xiao-Mao
          Chuan, Zhi-Rui
          Lv, Wen-Zhi
          Jiang, Fan
          Ni, Xue-Jun
          Cui, Xin-Wu
          Dietrich, Christoph F.
        affil: Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, 430030, Wuhan, Hubei Province, China
      sug:
        subj:
          Breast Neoplasms
          Retrospective Design
          Ultrasonography
          Comparative Studies
          Multicenter Studies
          Evaluation Research
          Validation Studies
          Scales
          Human
      ab: Objectives: To evaluate the prediction performance of deep convolutional neural network (DCNN) based on ultrasound (US) images for the assessment of breast cancer molecular subtypes.Methods: A dataset of 4828 US images from 1275 patients with primary breast cancer were used as the training samples. DCNN models were constructed primarily to predict the four St. Gallen molecular subtypes and secondarily to identify luminal disease from non-luminal disease based on the ground truth from immunohistochemical of whole tumor surgical specimen. US images from two other institutions were retained as independent test sets to validate the system. The models' performance was analyzed using per-class accuracy, positive predictive value (PPV), and Matthews correlation coefficient (MCC).Results: The model achieved good performance in identifying the four breast cancer molecular subtypes in the two test sets, with accuracy ranging from 80.07% (95% CI, 76.49-83.23%) to 97.02% (95% CI, 95.22-98.16%) and 87.94% (95% CI, 85.08-90.31%) to 98.83% (95% CI, 97.60-99.43) for the two test cohorts for each sub-category, respectively. In terms of 4-class weighted average MCC, the model achieved 0.59 for test cohort A and 0.79 for test cohort B. Specifically, the DCNN also yielded good diagnostic performance in discriminating luminal disease from non-luminal disease, with a PPV of 93.29% (95% CI, 90.63-95.23%) and 88.21% (95% CI, 85.12-90.73%) for the two test cohorts, respectively.Conclusion: Using pretreatment US images of the breast cancer, deep learning model enables the assessment of molecular subtypes with high diagnostic accuracy.Trial Registration: Clinical trial number: ChiCTR1900027676 KEY POINTS: • Deep convolutional neural network (DCNN) helps clinicians assess tumor features with accuracy. • Multicenter retrospective study shows that DCNN derived from pretreatment ultrasound imagine improves the prediction of breast cancer molecular subtypes. • Management of patients becomes more precise based on the DCNN model.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N